TrialThorax2013

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial.

William W Busse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.